V P Werth Selected Research

V P Werth Research Topics

Disease

6	Cutaneous Lupus Erythematosus 01/2019 - 10/2000
5	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2019 - 10/2000
4	Pemphigus (Pemphigus Vulgaris) 10/2021 - 02/2000
3	Discoid Lupus Erythematosus 01/2022 - 05/2012
3	Dermatomyositis (Dermatopolymyositis) 01/2020 - 10/2015
2	Autoimmune Diseases (Autoimmune Disease) 10/2021 - 01/2020
2	Disease Progression 01/2020 - 02/2000
2	Atrophy 01/2008 - 07/2000
2	Rheumatoid Arthritis 08/2000 - 02/2000
1	Myositis (Idiopathic Inflammatory Myopathies) 11/2019
1	Atopic Dermatitis (Atopic Eczema) 01/2018
1	Skin Diseases (Skin Disease) 01/2018
1	Pruritus (Itching) 01/2018
1	Infections 07/2017
1	Neoplasms (Cancer) 07/2017
1	Inflammation (Inflammations) 06/2015
1	Necrosis 01/2008
1	Dermatitis 01/2008
1	Infarction (Infarctions) 01/2008
1	Alopecia (Baldness) 01/2004
1	Oral Ulcer (Mouth Ulcer) 01/2004
1	Injection Site Reaction 07/2001
1	Communicable Diseases (Infectious Diseases) 10/2000
1	Erythema elevatum diutinum 08/2000
1	Lupus Nephritis 07/2000
1	Multiple Sclerosis 07/2000
1	Osteosarcoma (Osteogenic Sarcoma) 07/2000
1	Systemic Scleroderma (Systemic Sclerosis) 02/2000

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 11/2017 - 08/2000
2	AutoantibodiesIBA 10/2021 - 11/2019
2	Prostaglandins AIBA 07/2016 - 10/2015
2	Prednisone (Sone)FDA LinkGeneric 03/2015 - 07/2000
2	Etanercept (Enbrel)FDA Link 07/2001 - 08/2000
2	GlucocorticoidsIBA 07/2000 - 02/2000
1	Antinuclear AntibodiesIBA 01/2022
1	dimemorfan (AT 17)IBA 01/2022
1	DesmogleinsIBA 10/2021
1	Agammaglobulinaemia Tyrosine KinaseIBA 10/2021
1	baricitinibIBA 01/2019
1	InterleukinsIBA 01/2018
1	R333IBA 01/2018
1	Janus KinasesIBA 01/2018
1	Syk KinaseIBA 01/2018
1	VaccinesIBA 07/2017
1	Interleukin-1 (Interleukin 1)IBA 06/2015
1	Interleukin-18 (Interleukin 18)IBA 06/2015
1	ChemokinesIBA 06/2015
1	Interleukin-12 (IL 12)IBA 06/2015
1	Interleukin-6 (Interleukin 6)IBA 06/2015
1	Interleukin-10 (Interleukin 10)IBA 06/2015
1	Interleukin-17 (Interleukin 17)IBA 06/2015
1	CytokinesIBA 06/2015
1	Infliximab (Remicade)FDA Link 03/2015
1	AntibodiesIBA 01/2015
1	Interferon Type IIBA 05/2012
1	InterferonsIBA 05/2012
1	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 01/2008
1	MucinsIBA 01/2008
1	SS-B antibodiesIBA 01/2004
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2000
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 08/2000
1	Hyaluronan SynthasesIBA 07/2000
1	GlycosaminoglycansIBA 07/2000
1	Hyaluronic Acid (Hyaluronan)IBA 07/2000
1	Methylprednisolone FDA LinkGeneric 07/2000
1	RNA (Ribonucleic Acid)IBA 07/2000
1	Messenger RNA (mRNA)IBA 07/2000
1	Therapeutic UsesIBA 07/2000
1	Azathioprine (Imuran)FDA LinkGeneric 02/2000
1	Penicillamine (Cuprimine)FDA Link 02/2000

Therapy/Procedure

3	Therapeutics 01/2020 - 02/2000
1	Radiotherapy 07/2017
1	Biological Therapy 02/2017
1	Plasmapheresis 02/2000